Skip to main content

Together we are beating cancer

Donate now

News

Showing 12 out of 2993 results
Senedd in Wales.

Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales. Confusion over the symptoms of lung cancer and COVID-19 may be responsible for a drop in the number of people being referred for lung cancer tests in Wales.

by Cancer Research UK | News | 20 November 2020

20 November 2020

Lung cancer cells under a microscope

The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers. The Scottish Medicines Consortium (SMC) has approved 4 new cancer drugs for use on the NHS in Scotland to treat some lung, breast and prostate cancers.

by Cancer Research UK | News | 13 November 2020

13 November 2020

A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries. A crisis in charity research funding caused by the COVID-19 pandemic threatens to delay the pace of life saving discoveries.

by Cancer Research UK | News | 13 November 2020

13 November 2020

Cancer Research UK charity shop

Cancer Research UK’s 470 charity shops in England have closed for one month from 5 November, following the announcement of a national lockdown. Cancer Research UK’s 470 charity shops in England have closed for one month from 5 November, following the announcement of a national lockdown.

by Cancer Research UK | News | 6 November 2020

6 November 2020

An illustration of T cells (white) attacking a tumour (purple)

Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.    Some people with head and neck cancer will now have access to the immunotherapy drug pembrolizumab (Keytruda) on the NHS in England.   

by Cancer Research UK | News | 26 October 2020

26 October 2020

Older woman and doctor

53% of GPs say they are concerned that fewer older adults are contacting them with symptoms compared to before the pandemic, according to new findings 53% of GPs say they are concerned that fewer older adults are contacting them with symptoms compared to before the pandemic, according to new findings

by Cancer Research UK | News | 23 October 2020

23 October 2020

Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer.  Scientists from the University of Glasgow are developing new ways to predict who will respond to drugs targeting damaged DNA in pancreatic cancer. 

by Cancer Research UK | News | 12 October 2020

12 October 2020